Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Metagenomi, Inc. Common Stock · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $20.00M | $11.52M - $28.10M | -$20.00M | -$1.80 | 1 |
| Dec 2029 | $20.00M | $11.52M - $28.10M | -$20.00M | -$1.95 | 1 |
| Dec 2028 | $20.00M | $11.52M - $28.10M | -$20.00M | -$2.177 | 1 |
| Dec 2027 | $12.52M | $7.22M - $17.59M | -$12.52M | -$1.565 | 3 |
| Dec 2026 | $12.15M | $7.00M - $17.07M | -$12.15M | -$2.124 | 3 |
| Dec 2025 | $28.63M | $28.16M - $29.09M | -$28.63M | -$2.359 | 3 |
| Dec 2024 | $51.81M | $46.44M - $59.70M | -$51.81M | -$2.479 | 5 |
| Dec 2023 | $47.26M | $38.10M - $70.85M | -$47.26M | -$9.859 | 2 |